Join the New York State Department of Health AIDS Institute Clinical Education Initiative, Mount Sinai Institute for Advanced Medicine, Pharmacy Society of Rochester, and the Northeast/Caribbean AIDS Education and Training Center for an exciting half-day CE program! This program will discuss current epidemiological trends and clinical updates regarding HIV and Hepatitis C prevention and care.
Objectives
Antiretroviral Therapy
At the conclusion of this presentation, participants will be able to:
- Cite available antiretrovirals and their classification and new drug development
- Describe the dosing strategies of antiretrovirals and management of side effects and drug interactions
- Manage change in therapy
Pre-Exposure Prophylaxis (PrEP)
At the conclusion of this presentation, participants will be able to:
- Discuss the NYS and CDC Guidelines for Pre-Exposure Prophylaxis (PrEP)
- Describe selection of candidates for PrEP
- Discuss the management of the patient on PrEP
- Discuss PrEP therapy and side effects
- Discuss the challenges associated with PrEP
- Discuss follow-up care including labs, PrEP, and counseling
Treatment for Hepatitis C: New Tests, New Drugs, and New Recommendations
At the conclusion of this presentation, participants will be able to:
- Explain the epidemiology of the hepatitis C virus
- Discuss laboratory testing and diagnosis of HCV infection
- Design a therapeutic regimen and monitoring plan for the treatment of HCV
Accreditation
Continuing Pharmacy Education
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This live knowledge-based activity “Antiretroviral Therapy,” ACPE #0044-9999-16-037-L02-P, will award 1 contact hour or 0.10 CEUs of pharmacy education credit. No partial credit will be awarded.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This live knowledge-based activity “Pre-Exposure Prophylaxis,” ACPE #0044-9999-16-032-L02-P, will award 1 contact hour or 0.10 CEUs of pharmacy education credit. No partial credit will be awarded.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This live knowledge-based activity “Treatment for Hepatitis C: New Test, New Drugs, and New Recommendations,” ACPE #0044-9999-16-027-L01-P, will award 1 contact hour or 0.10 CEUs of pharmacy education credit. No partial credit will be awarded.
The following presenters have disclosed financial relationships within the last 12 months:
Kelly S. Ramsey, MD, MPH, MA, FACP: One time Advisory Board (Gilead)
John J. Faragon, PharmD, BCPS, AAHIV-P: Speaker’s Bureau (BMS, Janssen, Merck, Abbvie, Gilead), Consultant (Gilead, ViiV)
Other planners and faculty participants do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials.
